Kissei Pharmaceutical Co., Ltd.
4547.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥168 | ¥157 | ¥122 | ¥118 |
| - Cash | ¥25 | ¥23 | ¥26 | ¥30 |
| + Debt | ¥1 | ¥1 | ¥1 | ¥2 |
| Enterprise Value | ¥144 | ¥135 | ¥97 | ¥89 |
| Revenue | ¥88 | ¥76 | ¥67 | ¥65 |
| % Growth | 16.9% | 12% | 3.2% | – |
| Gross Profit | ¥44 | ¥37 | ¥32 | ¥31 |
| % Margin | 49.9% | 49.4% | 48% | 47.8% |
| EBITDA | ¥20 | ¥19 | ¥18 | ¥20 |
| % Margin | 22.9% | 24.8% | 26.4% | 31% |
| Net Income | ¥12 | ¥11 | ¥11 | ¥13 |
| % Margin | 13.5% | 14.8% | 15.6% | 19.8% |
| EPS Diluted | 274.2 | 246.58 | 228.3 | 280.19 |
| % Growth | 11.2% | 8% | -18.5% | – |
| Operating Cash Flow | ¥7 | -¥2 | -¥7 | ¥2 |
| Capital Expenditures | -¥5 | -¥2 | -¥3 | -¥2 |
| Free Cash Flow | ¥2 | -¥4 | -¥9 | -¥0 |